Lilly Will Play The Metabolism Card In Effient's Imminent U.S. Launch

Meanwhile, second-quarter sales of the oral platelet inhibitor outside the U.S. prove to be…thin.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet